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Cattle that are persistently infected (PI) with one strain of bovine viral diarrhea virus (BVDV) can resolve infection with a
second, antigenically heterologous strain but not the homologous strain. Since CD41 T cells are thought to be critical for the
resolution of acute BVDV infection (Howard et al., 1992, Vet. Immunol. Immunopathol. 32, 303–314), we have examined the
recognition of a heterologous virus (NADL) by CD41 T cells from Pe515-PI animals. The immune response of non-PI control
cattle challenged with NADL or Pe515ncp was strain cross-reactive, whereas Pe515-PI animals responded to NADL only. The
immune repertoire of both groups included NS3, which differs by approximately 1% (9/683) amino acids between these two
viruses. Lymphoproliferative responses to proteins and synthetic peptides corresponding to three nonconservative differ-
ences in NS3 demonstrated that CD41 T cells from non-PI control animals responded well to proteins but poorly to the
peptides from both viruses. In contrast, PI animals were responsive to heterologous proteins and peptides but nonresponsive
to the homologous equivalents. A single amino acid difference between the two sequences was sufficient to allow
responsiveness. © 2000 Academic PressKey Words: bovine viral diarrhea virus; persistent infection; heterologous challenge; immunological nonresponsiveness;
1 ynthetCD4 T-cell repertoire; B-cell repertoire; NS3 proteinase; s
INTRODUCTION
Bovine viral diarrhea virus (BVDV) is a positive-sense
RNA virus of the genus Pestivirus belonging to the family
Flaviviridae (Wengler, 1991). Two biotypes of the virus,
noncytopathic (ncp) and cytopathic (cp), are distin-
guished by their effects in tissue culture. BVDV infection
of naı¨ve cattle generally results in either asymptomatic or
mild clinical symptoms and is characterized by transient
viremia, nasal shedding, and leukopenia followed by the
production of neutralizing antibodies (Malmquist, 1968).
In recent years, cases of a severe and sometimes fatal
acute disease associated with genotype II ncp-BVDV
infections have been reported (Bolin and Ridpath, 1992;
Pellerin et al., 1994).
Persistent infection (PI) can arise when a fetus is
infected by ncp-BVDV in utero during the first trimester of
pregnancy (i.e., prior to immunological incompetence).
Such animals remain lifelong carriers and usually do not
produce antibody to the persisting virus. Experimental
superinfection of PI animals with antigenically similar or
identical (homologous) cp virus results in an acute, in-
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70ic peptides.
variably fatal condition known as mucosal disease (MD)
and the animals die without making antibody against the
challenge virus (Bolin et al., 1985a; Brownlie et al., 1984).
These observations gave rise to the suggestion that PI
animals are immunologically tolerant to the persisting
virus (Bolin et al., 1985b; Brownlie et al., 1984; Coria and
McClurkin, 1978; Larsson and Fossum, 1992; McClurkin
et al., 1984). That this putative tolerance is specific to the
persisting virus is suggested by the finding that PI ani-
mals can resolve infections with antigenically dissimilar
(heterologous) isolates (Bolin et al., 1985b; McClurkin et
al., 1984). However, formal evidence of tolerance to the
persisting virus and a definition of the mechanism are
lacking.
The invariable isolation of pairs of ncp and cp viruses
from animals that die from MD (Greiser-Wilke et al., 1993;
McClurkin et al., 1985; Moennig et al., 1990; Wilhelmsen
et al., 1991) suggested that antigenically homologous cp
virus arises by recombination or by mutation of the ncp
genome. Examples of recombination events that have
been characterized are reviewed in Meyers and Thiel
(1996). However, MD can also occur following heterolo-
gous or semihomologous challenge (Bolin et al., 1985a,b;
Bruschke et al., 1998; Fray et al., 1998; Fritzemeier et al.,
1997; Ridpath and Bolin, 1995; Shimizu et al., 1989). In
this situation, the disease has a delayed onset and the
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challenge virus prior to the onset of MD. Low levels of
neutralizing antibody against the homologous virus have
also been reported (Brock et al., 1998; Collins et al., 1999;
Edwards et al., 1991), although it is unclear whether this
response is against the homologous virus or an adven-
titious heterologous infection. Both early- and delayed-
onset MD are consistent with the same model for patho-
genesis but differ in that the delayed form takes a finite
but variable time for the generation of homologous cp
virus to occur.
Infection of non-PI cattle results in the production of
neutralizing antibodies that confer protection against re-
infection. Acquisition of maternal antibody by PI calves
can reduce virus titers but does not clear the PI virus
(Howard et al., 1989). The preceding observations sug-
gest that antibody alone is insufficient to effect the res-
olution of BVDV infection. Studies involving in vivo deple-
tion of T-cell subsets have demonstrated that disease
resolution in BVDV naı¨ve, non-PI calves is strongly de-
pendent on the CD41 T-cell population (Howard et al.,
1992). The repertoire and effector functions of CD41 T
cells have still to be determined with respect to clear-
ance of BVDV.
In this study we have examined the ability of CD41 T
cells from Pe515-PI calves to recognize proteins and
peptides from the homologous ncp/cp virus pair and a
defined heterologous cp challenge utilizing experimen-
tally produced, gnotobiotically derived PI animals
housed in high disease security accommodation. We
demonstrate that the PI calves are nonresponsive to the
homologous virus in vitro, both at the level of neutralizing
antibody and lymphoproliferation, and extend these ob-
servations to demonstrate CD41 T-cell response to NS3
T
Virus Isolation from Nasopha
Animal Persistent virus Challenge vi
51/96 n.a.a Pe515ncp
5334 n.a.
582 n.a. NADL
591 n.a.
5172 Pe515ncp NADL
32/96 Pe515ncp NADL
33/96 Pe515ncp NADL
36/96 Pe515ncp NADL
a n.a. 5 not applicable (i.e., non-PI).
b 1 5 virus detected. Numbers in parentheses represent the day(s) w
Pe515ncp 5 noncytopathic).
c 2 5 challenge virus not detected.
T-CELL RECOGNITION OF HEof the challenge virus. Responses to synthetic peptides
indicate that limited sequence differences between the
r
(homologous and the heterologous viruses can be suffi-
cient for T-cell recognition of the heterologous virus
strain.
RESULTS
Clinical status of animals
Prior to experimental infection, all of the animals were
tested on two occasions at 3-week intervals for the
presence of BVDV-specific antibody and viremia. None of
the animals had detectable circulating neutralizing anti-
body and only the four PI animals were viremic (107.060.7
TCID50/ml). The four PI animals and two non-PI animals
were challenged with NADL and the other two non-PI
animals were infected with Pe515ncp. Following chal-
lenge, ncp virus was isolated from all of the PI calves and
the two Pe515ncp-infected, non-PI animals, and cp virus
was isolated from three of the PI calves (5172, 32/96, and
33/96) and the two NADL-infected, non-PI animals (Table
1). At the peak of viremia the viral burden was 106.960.7
TCID50/ml ncp virus for the Pe515ncp control animals,
106.360.6 TCID50/ml cp virus for the NADL control animals,
and 105.360.5 TCID50/ml cp virus for the PI calves. Virus
as recovered more frequently from nasal secretions
han from blood and all animals cleared the challenge
irus by 19 days postinfection (d.p.i.).
eterologous challenge of PI cattle induces specific
mmunity with restricted antibody specificity
All of the animals seroconverted by 14 d.p.i. following
xperimental challenge. Cross-neutralizing antibodies
eactive with Pe515ncp and NADL were detected in the
erum of the non-PI animals (5334, 51/96, 582, 591).
e515-PI animals produced neutralizing antibodies that
l Swabs and Blood Samples
Virus isolation
Blood Nasal swab
1b (5, 7, 12) 1 (2, 5, 7, 9, 12, 14, 17)
1 (5, 7, 9, 14) 1 (5, 7, 9, 12, 14, 17)
1 (12) 1 (5, 12)
1 (14) 1 (12)
1 (5, 9) 1 (5, 7, 9)
1 (9, 12) 1 (5, 12)
1 (9) 1 (5, 12)
2c 2
ampling was positive for challenge strain biotype (NADL 5 cytopathic,
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TEROLeacted with NADL but not Pe515ncp (5172, 32/96, 33/96)
Fig. 1).
re collected at various times after infection and assayed against 100 TCID50The specificity of antibody was examined by immuno-
precipitation/Western blot analysis of NADL and Pe515cp
antigens. Precipitation of Pe515 proteins was carried out
against Pe515ncp and Pe515cp (homologous pair). Only
the results for Pe515cp are presented to show NS3 as a
discrete viral product. Representative results from a
non-PI animal (591) and a PI animal (5172) are shown in
Fig. 2. At 56 d.p.i., antibodies from the non-PI animals
recognized a range of viral proteins from Pe515cp and
NADL. Interestingly, the protein profiles obtained using
Pe515cp and NADL antigens grown for 24 h were very
similar (Fig. 2, lanes 1 and 2), as were the profiles
obtained using Pe515cp grown for 24 or 40 h (data not
shown). However, the NS2-3 band obtained when using
40-h NADL lysate was fainter than that for the 24-h lysate
(data not shown). Serum antibodies from the PI animals
recognized none of the Pe515cp proteins and only one of
the NADL proteins. Of the PI animals, only animal 5172
was kept for more than 84 d.p.i. Serum antibodies sam-
pled at 84 d.p.i. (data not shown) and 112 d.p.i. (Fig. 2)
were found to recognize both NADL and Pe515 viruses
with respect to E2, NS3, and NS2-3 (Fig. 2, lanes 5 and 6).
Homologous neutralizing antibody activity was not de-
FIG. 1. Virus-neutralizing activity of sera collected from non-PI cat
Pe515ncp-PI cattle challenged with NADL (5172, 32/96, 33/96). Sera we
of either Pe515ncp (hatched bars) or NADL (filled bars).
72 COLLtle challenged with either NADL (582, 591) or Pe515ncp (5334, 51/96) and
EN ET AL.tected at any time point.
These data confirm that PI animals are capable ofFIG. 2. Immunoprecipitation/Western blot analysis of virus proteins
reacted with serum obtained from non-PI and Pe515ncp-PI calves
challenged with NADL. Viral proteins were immunoprecipitated using
56 and 112 d.p.i. serum and resolved by 12.5% SDS–PAGE under
reducing conditions. Proteins were transferred to nitrocellulose, probed
with biotinylated anti-BVDV IgG, and detected by ECL. The figure shows
representative data from a non-PI calf (591) at 56 d.p.i. (lanes 1 and 2)
and a PI calf (5172) at 56 d.p.i. (lanes 3 and 4) and 112 d.p.i. (lanes 5 and
6) for Pe515cp antigen (lanes 1, 3, and 5) or NADL antigen (lanes 2, 4,
and 6). Precipitation of Pe515 proteins was carried out against
Pe515ncp and Pe515cp, but only the results for Pe515cp are presented
to show NS3 as a discrete viral product.
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TEROLmaking an antibody response following challenge with a
heterologous BVDV isolate and that, at least up to Day 56
after challenge, the antibody produced is largely specific
for the challenge virus.
CD41 T cells from heterologously challenged PI cattle
roliferate in response to the challenge virus but not
ersisting-virus antigens
To determine whether Pe515 proteins were antigenic
n Pe515-PI cattle, PBMC from non-PI and PI animals
ere assayed at weekly intervals against varying con-
entrations of mock and BVDV antigens in proliferation
ssays.
The maximum difference between mock and viral an-
igens was obtained using a 1:40 dilution of antigen, and
nder these conditions non-PI cattle responded to
e515ncp by 42–56 d.p.i. and to NADL by 21 d.p.i.
e515-PI cattle challenged with NADL also responded to
ADL antigen by 21 d.p.i. The four non-PI cattle re-
ponded to both Pe515 and NADL antigen, whereas the
hree PI cattle responded to NADL only (Figs. 3 and 4).
PBMC from PI animals secrete live virus into assay
ultures. To test whether the presence of live ncp virus
nfluenced the ability of PBMC to respond to sonicated
ntigens, PBMC from non-PI animals were cocultured
ith 1:40 mock, Pe515ncp, or NADL antigen in the pres-
nce of 0, 0.05, 0.5, 5, or 20 m.o.i. of infectious Pe515ncp.
he results indicated that there was an increased prolif-
rative response to sonicate antigens that was maximal
t 0.5 m.o.i. (24%). The addition of live virus did not
dversely affect proliferative responses to sonicate anti-
ens at any of the m.o.i.’s tested (results not shown).
The sonicated viral antigens used to screen T-cell
esponses comprise a complex mixture of viral and cel-
ular proteins of which viral proteins are a relatively
inor component. To test whether proliferative re-
ponses were influenced by the purity of viral antigen,
BMC from non-PI and PI cattle were stimulated with
arying concentrations of beads carrying affinity-cap-
ured proteins. Figure 3 shows representative responses
f non-PI and PI animals. Responses were stimulated by
ntigens captured with monoclonal antibodies (MAbs)
pecific for Erns, E2, and NS3. The non-PI animals re-
sponded to proteins from both viruses, whereas the PI
animals responded to NADL only. The antigen dilutions
that gave a positive response extended over a greater
range than for the crude sonicate antigens (6.25 3 103–
3 105 beads/well) (data not shown).
The MAbs used for the immunocapture of BVDV anti-
ens are specific for discrete viral proteins. However,
estern blot analysis of affinity-captured antigen indi-
ated that the immunocaptured preparations contained a
T-CELL RECOGNITION OF HEredominance of the target protein but that they were not
ure. Thus, Erns and E2 were present in the antigensprepared with either the E2- or Erns-specific MAbs, re-
pectively. Similarly, antigen prepared with the NS3-spe-
ific MAb contained both NS3 and the precursor protein
S2-3. To further examine the response to these pro-
eins, NADL and Pe515cp proteins were resolved by
DS–PAGE and prepared as nitrocellulose-bound anti-
ens. Only NS3 was resolved to a discrete band. Figure
shows that PBMC from the non-PI cattle were stimu-
ated by nitrocellulose-bound NS3 from both viruses,
hereas PBMC from the PI cattle were stimulated by
S3 from NADL only. All three PI calves responded to the
S3 (80-kDa) preparation and two of the animals (5172
nd 33/96) responded to a fraction corresponding to
8–53 6 4 kDa (data not shown). Control responses
gainst equivalent fractions from mock-infected antigen
ere negative, although slightly higher than medium
lone.
These data demonstrate that PI animals are capable
f making a T-cell response following challenge with a
eterologous BVDV isolate and confirm nonresponsive-
ess to homologous virus proteins.
D41 T cells from heterologously challenged PI cattle
an recognize single amino acid differences between
hallenge and persistent virus NS3 proteinase
NADL-immune, Pe515-PI cattle were responsive to
S3 from NADL but nonresponsive to NS3 from Pe515.
o determine that 1% sequence variation between the
roteins was sufficient to account for responsiveness to
he heterologous NS3, PBMC were stimulated with vary-
ng concentrations of chemically synthesized peptides in
roliferation assays.
A pair of peptides that correspond to a single substi-
ution at position 1892 (R 7 T) (p1 and p2, Table 2) and
second pair of peptides that correspond to two closely
ocated substitutions at positions 2353 (G7 S) and 2360
T 7 A) (p3 and p4, Table 2) were tested for recognition
y T cells from the Pe515-PI and non-PI control cattle.
BMC from the three NADL-immune, Pe515-PI cattle
esponded to the NADL-derived peptide p3 (NADL:
343–2369) but not to the equivalent Pe515ncp-derived
eptide p4 (Pe515: 2343–2369) (Fig. 5). In contrast, weak
esponses, as defined by proliferation at 10 mg/ml but not
at 2 mg/ml or lower, were observed against the Pe515-
derived peptide p4 for the Pe515ncp-immune, non-PI
animal 5334, and against the NADL-derived peptide p3
for the NADL-immune, non-PI animal 591 (Fig. 5).
A C-terminally truncated version of p3, peptide p5
(NADL: 2343–2359), which contained only the position
2353 (G 7 S) substitution, was recognized by Pe515-PI
calf 5172 with similar magnitude and dose kinetics to that
of the longer peptide, p3. An N-terminally truncated ver-
73OGOUS BVDV BY PI CATTLEsion of p3, peptide p7 (NADL: 2343–2369), which over-
lapped with p5 by six residues and contained only the
FIG. 3. Proliferation by PBMC in response to enriched BVDV proteins. BVDV proteins from NADL or Pe515cp were captured on paramagnetic beads
coated with monoclonal antibodies specific for Erns, E2, or NS3, as described under Materials and Methods. The figure shows representative data
from a non-PI calf (591) and a PI calf (5172) assayed at 35 d.p.i. PBMC (1 3 105/well) were stimulated with mock antigen (1:40 final dilution), BVDV
antigen (1:40 final dilution), or enriched antigen (5 3 104 beads/well) prepared from mock (open bars), NADL (filled bars), or Pe515cp (hatched bars)
74 COLLEN ET AL.antigens and cultured for 6 days at 37°C. Responses are presented as the geometric means (61 SE) of c.p.m. (591: medium only, 1209; PWM, 121,981;
5172: medium only, 78; PWM, 118,673).FIG. 4. Proliferation by PBMC in response to nitrocellulose-bound NS3 antigen. Nitrocellulose-bound NS3 was prepared from NADL or Pe515cp
and used to stimulate PBMC from non-PI calves challenged with either Pe515ncp (5334, 51/96) or NADL (582, 591), and three Pe515ncp-PI calves
challenged with NADL (5172, 32/96, 33/96) at 42 and 63 d.p.i. for the NADL- or Pe515-infected cattle, respectively. PBMC (1 3 105/well) were incubated
with a 1:40 final dilution of mock antigen, BVDV antigen, or nitrocellulose-bound NS3 prepared from mock (open bars), NADL (filled bars), or Pe515cp
(hatched bars) antigens and cultured for 6 days at 37°C. Responses are presented as the geometric means (61 SE) of c.p.m. (582: medium only, 1198;
PWM, 97861; 591: medium only, 1301; PWM, 122,298; 51/96: medium only, 1282; PWM, 102,761; 5334: medium only, 1173; PWM, 128,851; 5172: medium
only, 87; PWM, 117,815; 32/96: medium only, 112; PWM, 101,811; 33/96: medium only, 71; PWM, 87,413).
DL (Co
(1988).
1position 2360 (T 7 A) substitution, was only weakly
recognized. Weak responses were also observed for the
other two Pe515-PI animals with peptides p1 (NADL:
T
Synthetic Peptides Representing Amino Acid Seque
Virus Peptide No.
...
NADL p1 SGI
Pe515ncp p2 SGI
...
NADL p3 DPG
Pe515ncp p4 DPG
NADL p5 DPG
Pe515ncp p6 DPG
NADL p7
Pe515ncp p8
a Peptides synthesised according to the sequences published for NA
is given with respect to the numbering used for NADL in Collett et al.
FIG. 5. Proliferation by PBMC in response to synthetic peptides. Syn
amino acid differences between Pe515ncp (open symbols) and NADL (c
with either Pe515ncp (5334, 51/96) or NADL (582, 591), and three Pe51
for the NADL- or Pe515-infected cattle, respectively. PBMC (1 3 105/we
0 to 0.08 mg/ml and cultured for 6 days at 37°C. Responses are prese
T-CELL RECOGNITION OF HE591: medium only, 1279; PWM, 92,312; 51/96: medium only, 1165; PWM, 84,212
76,532; 32/96: medium only, 91; PWM, 71,520; 33/96: medium only, 89; PWM,1873–1891), p3, p5, and p7 (Figs. 5 and 6) and for non-PI
calf 591 with peptides p5 and p7.
Taken together, these data confirm the induction of
rom NS3a of NADL and Pe515ncp Strains of BVDV
eptide Sequencea Difference
......1890.
NRADLTEMVKK R1882
NTADLTEMVKK T1882
......2360.........
ETGKALKQVTGLSSAENAL G2353/T2360
ETSKALKQVAGLSSAENAL S2353/A2360
ETGKALKQV G2353
ETSKALKQV S2353
KALKQVTGLSSAENAL T2360
KALKQVAGLSSAENAL A2360
llett et al., 1988) and Pe515 (Meyers et al., 1992). Sequence numbering
peptides corresponding to the sequence of NS3 (Table 2) at selected
symbols) were used to stimulate PBMC from non-PI calves challenged
I calves challenged with NADL (5172, 32/96, 33/96) at 49 and 70 d.p.i.
incubated with peptide (E, p1; F, p2) over a concentration range from
the geometric means of c.p.m. (582: medium only, 1209; PWM, 87,442;
75OGOUS BVDV BY PI CATTLEABLE 2
nces f
P
.1880
QTVSK
QTVSK
.2350
NQQVV
NQQVV
NQQVV
NQQVV
TEROLthetic
losed
5ncp-P
ll) were
nted as; 5334: medium only, 1063; PWM, 81,201; 5172: medium only, 84; PWM,
84,223).
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33/96:NS3-reactive T cells following acute heterologous BVDV
infection of PI animals and demonstrate that the immune
repertoire of PI animals can exploit minimal or even
single amino acid differences to distinguish between the
homologous and heterologous viruses.
DISCUSSION
The primary aim of this study was to establish an
experimental model that would allow us to examine
nonresponsiveness to BVDV in PI cattle. BVDV-PI calves
were generated experimentally using a cloned ncp iso-
late of Pe515 (Brownlie et al., 1984) and the resulting
nimals were housed in disease-secure accommoda-
ion. In vitro comparison of B-cell and T-cell responses of
I and non-PI animals to a heterologous virus challenge
emonstrated that the CD41 T-cell repertoire of PI ani-
mals is tolerant to the homologous virus and gave an
indication of the extent of sequence difference required
FIG. 6. Proliferation by PBMC in response to synthetic peptides. Syn
amino acid differences between Pe515ncp (open symbols) and NADL (c
with either Pe515ncp (5334, 51/96) or NADL (582, 591), and three Pe51
the NADL- or Pe515-infected cattle, respectively. PBMC (1 3 105/well)
concentration range from 10 to 0.08 mg/ml and cultured for 6 days at 37
only, 1209; PWM, 87,442; 591: medium only, 1279; PWM, 92,312; 51/96: m
medium only, 84; PWM, 76,532; 32/96: medium only, 91; PWM, 71,520;
76 COLLfor CD41 T cells to discriminate between the homolo-
ous and heterologous virus antigens.
e
IPersistently infected animals and strain-specific non-
esponsiveness to ncp-BVDV arise through in utero in-
ection prior to the fetus’s becoming immunocompetent.
hen PI animals are challenged postnatally by homolo-
ous cp virus, it is speculated that tolerance to the PI
irus is responsible both for the failure of these animals
o produce neutralizing antibody and for uncontrolled
eplication and viral cytopathology (Bolin et al., 1985b;
Brownlie et al., 1984; McClurkin et al., 1984). This model
is supported by the invariable recovery of antigenically
homologous ncp/cp virus pairs from animals that have
died from mucosal disease (MD) (Greiser-Wilke et al.,
1993; McClurkin et al., 1985; Moennig et al., 1990; Wil-
elmsen et al., 1991). However, antigenic analyses of
iruses isolated from field cases of MD and experimental
nfections using uncloned viruses indicate that MD can
lso be induced by heterologous viruses (Bolin et al.,
985b; Bruschke et al., 1998; Fray et al., 1998; Fritzemeier
peptides corresponding to the sequence of NS3 (Table 2) at selected
symbols) were used to stimulate PBMC from non-PI calves challenged
lves challenged with NADL (5172, 32/96, 33/96) at 49 and 70 d.p.i. for
cubated with peptide (E, p3; F, p4; , p5; , p6; M, p7; f, p8) over a
ponses are presented as the geometric means of c.p.m. (582: medium
only, 1165; PWM, 84,212; 5334: medium only, 1063; PWM, 81,201; 5172:
medium only, 89; PWM, 84,223).
AL.thetic
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5-PI ca
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°C. Res
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n this situation, MD has a delayed onset and the ani-
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TEROLmals produce neutralizing antibodies against the chal-
lenge virus prior to the onset of MD. Both early- and
delayed-onset MD are consistent with the same model
for pathogenesis but differ in that the delayed form takes
a finite but variable time for the generation of homolo-
gous cp virus. In the short-term, challenge with a heter-
ologous virus generally leads to resolution of infection,
production of antibodies to the challenge virus (Bolin et
al., 1985a; McClurkin et al., 1984), and, occasionally, low
evels of antibodies to homologous virus (Brock et al.,
998; Collins et al., 1999; Edwards et al., 1991).
It has been suggested that the lack of antibody pro-
uction to the homologous virus by PI cattle is the result
f B-cell tolerance (Larsson et al., 1990; Malmquist,
968). In our study, heterologous infection of PI cattle
esulted in seroconversion (Fig. 1) and clearance (Table
) of the challenge virus without affecting the persisting
irus. After challenge, the antibody repertoire of the PI
nimals was very restricted compared to that of the
on-PI cattle (Fig. 2), such that by 56 d.p.i., the non-PI
attle recognized most proteins from both virus-
s,whereas the PI animals recognized only heterologous
2. Interestingly, at both 84 and 112 d.p.i., serum from PI
alf 5172 had reactivity with E2 and NS3 from both
iruses. These sera were able to neutralize NADL and
recipitate both homologous and heterologous E2, but
ere nonneutralizing for both biotypes of the Pe515 virus
air. The data described are consistent with other stud-
es in which antibody to homologous PI virus has been
etected following heterologous challenge (Bolin, 1988;
rock et al., 1998; Donis and Dubovi, 1987). The produc-
ion of antibodies reactive with the homologous virus
ndicates that the B-cell repertoire of PI cattle can include
he homologous virus. Activation of B cells specific for
omologous virus, albeit under undefined circum-
tances, suggests that B-cell tolerance may be incom-
lete.
Using lymphoproliferation as a correlate of CD41 T-
cell response (Collen and Morrison, 2000), the CD41
T-cell repertoire of non-PI animals was strain cross-
reactive, whereas that of the NADL-immune, Pe515-PI
animals was NADL specific (Figs. 3 and 4). Responses to
enriched proteins from NADL or Pe515cp demonstrated
that the CD41 T-cell repertoire of non-PI and PI calves
included Erns, E2, and NS2-3/NS3 and recognition of NS3
was confirmed using protein extracted from SDS–PAGE
gels. Importantly, we found no evidence that homologous
antigens were recognized at any level of purity tested,
suggesting that the nonresponsiveness of the Pe515-PI
calves to Pe515-sonicate antigen was not simply a prop-
erty of the complex protein mixture or the high concen-
tration of cellular proteins. In addition, coculture of son-
icate and live virus antigens provided no indication that
T-CELL RECOGNITION OF HEinfectious virus released by PI-PBMC might compromise
responses, either directly through infection or by high
c
tzone tolerance. Others have used live virus stimulation to
study T-cell responses (Lambot et al., 1997; Larsson and
Fossum, 1992). Thus, our data are consistent with the
view that the T-cell repertoire of PI animals is tolerant to
the homologous PI virus. Nonresponsiveness to homol-
ogous antigens was observed for at least 16 weeks post
heterologous infection, suggesting that the CD41 T-cell
tolerance is complete.
NADL was used to challenge the PI animals because
(1) it is antigenically heterologous to Pe515, (2) it is the
basis of an attenuated live vaccine licensed for use in
North America, and (3) its genome has been fully se-
quenced (Collett et al., 1988). However, it has been sug-
gested that immune responses to cp and ncp viruses are
regulated differently (Lambot et al., 1997, 1998). Thus, the
trength of the lymphoproliferative response to NADL,
nd to NS3 in particular, could reflect a Th1 bias intro-
uced by the choice of challenge virus. However, cattle
nfected with either Pe515cp or Pe515ncp both recognize
eterologous NS3 (Collen and Morrison, 2000; Lambot et
l., 1997), demonstrating that lymphoproliferative recog-
ition of NS3 is not dependent on the choice of biotype
sed for challenge. Thus, heterologous cp challenge is a
seful tool for the analysis of the CD41 T-cell repertoire
f PI cattle, with the caveat that the bias of target anti-
ens and effector responses overall may differ for acute
cp and cp infections or between non-PI and PI cattle
nd will require further studies.
NS3 of NADL (Collett et al., 1988) and Pe515ncp (Mey-
rs et al., 1992) differ by nine out of 683 amino acids.
esponses to synthetic peptides corresponding to three
onconservative substitutions suggested that the PI an-
mals were more responsive than were the non-PI ani-
als to the same viral sequences. Lack of or weak T-cell
ecognition of determinants might result if (1) test pep-
ides did not correspond to the sequence of the priming
irus, (2) the sequences selected are unable to bind the
HC molecules of a particular animal, or (3) the se-
uences selected represent subdominant or cryptic de-
erminants. In this study, animals were challenged with
ADL-Weybridge (Paton et al., 1992) and the animals
sed were of undefined MHC haplotype. Although there
as no prior evidence to suggest that any of the peptides
ested would be antigenic, several animals made good
esponses to one or more of the peptides, suggesting
hat the poorer responsiveness of the non-PI cattle was
ot the result of a mismatch between the challenge
iruses and peptide sequences.
Furthermore, in a separate study, we have shown that
he dominant determinants for two defined MHC class II
aplotypes are located in regions that are separate from
he substitutions examined in the present study (in prep-
ration). We suggest that the regions examined in the
77OGOUS BVDV BY PI CATTLEurrent study constitute subdominant determinants. In-
erestingly, the dose kinetics of animal 5172 and the
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EN EToverlapping reactivity of peptides p3 and p5 suggest that
residues 2343–2359 contain a T-cell determinant for this
animal. In this context, the proline at position 22 could
indicate a processing motif such that the G 7 S substi-
tution would fall within the core epitope as defined by
Falk et al. (1994). For the other two PI animals, peptide
p3, but neither p5 nor p7, was recognized. Since peptides
p5 and p7 overlap with each other and with p3, we can
speculate that the determinant recognized by these an-
imals resides toward the middle of p3 (e.g., neither fully
in p5 nor fully in p7). Thus, for these animals either the
G7 S or T7 A substitutions, or both together, could be
responsible for heterologous responsiveness.
We propose the following model to explain tolerance
in BVDV-PI animals and how such animals might pro-
duce antibody to the persisting virus. During the induc-
tion of tolerance, PI-T cells specific for BVDV-infected
cells become suppressed as if the BVDV proteins were
self-antigens. Antigen-presenting cells (APC) expressing
both dominant and subdominant viral T-cell epitopes can
act as a bridge to bring locally suppressive, regulatory T
cells into close proximity with naı¨ve CD41 T cells and
thereby cause suppression of the naı¨ve T cells (linked
suppression) (Davies et al., 1996; Hoyne et al., 1997; Wise
et al., 1998). If the priming antigen is always present, as
it is in a persistent virus infection, dominant and sub-
dominant epitopes would both remain under negative
regulation and effector responses would be compro-
mised through lack of T-cell help. In contrast, tolerance
for the effector cell populations may be incomplete and,
given sufficient or appropriate T-cell help, they could be
made to respond. Self-tolerance to virus proteins medi-
ated by tissue-specific expression of genes in transgenic
mice can be overcome by presentation of that protein in
association with foreign T-cell epitopes, provided either
through full virus infection or by immunization with a
carrier-protein conjugate (Steinhoff et al., 1994). Thus, on
challenge with heterologous BVDV, PI cattle can respond
by recognizing differences between the persisting and
challenge viruses.
Moreover, several studies have demonstrated that
CD41 T cells specific for one protein of a complex anti-
en, or an epitope of that protein, can provide help to B
ells specific for a different protein of the same complex
ntigen (Milich et al., 1987; Russell and Liew, 1979;
cherle and Gerhard, 1988). Such help is most efficient
hen B-cell and T-cell epitopes are closely associated
n the same protein but can also occur with decreasing
fficiency, as epitopes become separated on the same
rotein or between proteins present in the same APC.
hus, in the case of BVDV, help for B cells specific for E2
ould be provided by CD41 T cells specific for NS3, or
vice versa, if both are presented by the same APC. Such
78 COLLlimitations could account for the highly selective anti-
body response that we observed in this study (Fig. 2). Inour study, the recognition of synthetic peptides with lim-
ited sequence differences suggests that regions of viral
proteins with minimal substitutions could be sufficient to
provide linked recognition. Clearly, the greater variability
of E2 compared to NS3 would greatly increase the prob-
ability of such an outcome.
The results reported here highlight the importance of
even single amino acid differences between BVDV iso-
lates in overcoming nonresponsiveness in PI cattle. We
propose that tolerance of the CD41 T-cell repertoire,
together with a critical dependence on CD41 T-cell help
or effector responses, is sufficient to account for the
onresponsive character of PI animals. Although the
umber of animals in this study is small and the conclu-
ions may be highly speculative, the data support a
odel for tolerance and responsiveness that can be
ested more rigorously.
MATERIALS AND METHODS
iruses
The Pe515 and NADL viruses used in this study are
ntigenically heterologous, genotype I isolates of BVDV.
he Pe515 viruses were a homologous pair of cloned
ytopathic (cp) and noncytopathic (ncp) isolates that
ave been described previously (Brownlie et al., 1984).
The NADL isolate was originally obtained from Central
Veterinary Laboratories (Weybridge, UK) and then prop-
agated at IAH-Compton (M. C. Clarke, personal commu-
nication).
Antibodies
BVDV-specific monoclonal antibodies WB112 (anti-
NS3), WB162 (anti-E2), and WB210 (anti-Erns) have been
escribed previously (Edwards et al., 1988; Paton et al.,
991). Biotinylated polyclonal anti-BVDV immunoglobulin
2331-B) was prepared from serum that had a high neu-
ralizing antibody titer, and recognized all major BVDV
roteins by immunoprecipitation and immunoblotting.
he IgG fraction was purified and concentrated on a
rotein G column and biotinylated using sulfo-NHS-LC-
iotin (Pierce and Warriner UK, Chester, UK).
ells and media
MDBK cells were provided by the Tissue Culture sec-
ion of this Institute and were cultured in Dulbecco’s
odified minimal essential medium (DMEM) containing
0% (v/v) fetal calf serum (FCS) that was free from BVDV
nd BVDV-specific antibody, 2 mM glutamine, 30 mM
gCl2, 0.25% (w/v) lactalbumin hydrolysate, 100 U/ml
enicillin, 100 mg/ml streptomycin, and 5 mg/ml ampho-
tericin B (complete DMEM). Maintenance medium was
AL.as described for complete DMEM but contained only 2%
(v/v) FCS. Bovine PBMC were cultured in RPMI 1640
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TEROLcontaining 5% (v/v) heat-inactivated FCS, 2 mM glu-
tamine, 1 mM sodium pyruvate, 25 mM HEPES, 0.05 mM
2-mercaptoethanol, and 10 mg/ml gentamicin sulfate
complete RPMI).
nimals
Two pairs of virus-free, BVDV antibody-negative Frie-
ian calves aged between 4 and 7 months were housed
n the medium security accommodation at the Compton
aboratory of the Institute for Animal Health. The calves
ere infected with 5 3 106 TCID50 of either Pe515ncp
(animals 5334 and 51/96) or NADL (animals 582 and 591)
by the intranasal route.
The BVDV PI calves used in this study were produced
by surgical infection of fetuses. Briefly, six pregnant cows
were presented for fetal infection at approximately 60
days of gestation. Following laparotomy, 5 ml of cell
culture fluid containing 106 TCID50 of Pe515ncp was
injected directly into the amniotic fluid. The incision was
repaired by standard surgical procedures and routine
antibiotic treatment given. PI calves were derived by
hysterotomy at approximately 10 days before term and
each calf was delivered into a sterile isolator and then
transferred to high disease security accommodation. The
calves were fed BVDV-free, BVDV antibody-free co-
lostrum within 6 h of birth. Blood samples were collected
and the PI status of the calves was confirmed by seeding
buffy coat cells onto a permissive cell substrate (MDBK
cells) followed 4–5 days later by immunoperoxidase
staining to detect viral antigens (Smith et al., 1988). One
Friesian PI calf (animal 5172) and three Aberdeen Angus
PI calves (animals 32/96, 33/96, and 36/96) were chal-
lenged with the NADL strain of BVDV at approximately 4
months of age using the same dose and route as that
described for the non-PI animals. Nasal swabs and
blood samples were collected at 228, 27, 22, 0, 2, 5, 7,
9, 12, 14, 17, and 21 d.p.i. Each sample underwent one
cycle of freezing and thawing before being seeded onto
MDBK cell cultures. The virological status of the animals
was determined by examination of the cultures for ab-
sence of cytopathic effect followed by immunoperoxi-
dase staining to detect viral proteins. Blood samples
were collected weekly into preservative-free heparin for
the isolation of peripheral blood mononuclear cells
(PBMC) to determine the ability of the animals to mount
proliferative cell-mediated responses. All of the calves,
except Pe515-PI animal 36/96, were successfully in-
fected by the specified challenge virus; 36/96 is not
reported further.
Preparation of mock and viral antigens
T-CELL RECOGNITION OF HEBVDV was propagated in MDBK cells overlayed with
maintenance medium. The expression of BVDV proteins
g
lin infected cells was confirmed by immunoperoxidase
staining using 2331-B as the BVDV probe.
Uninfected (mock antigen) and virus-infected (BVDV
antigen) MDBK cells were treated as described previ-
ously (Collen and Morrison, 2000). Briefly, 850-cm2 roller
ottles of MDBK cells were infected with BVDV at a
ultiplicity of infection (m.o.i.) of 0.1 TCID50/cell for 90
in at 37°C. Cells were overlayed with maintenance
edium and incubated at 37°C with continuous rolling.
nfected cells were detached using a cell-scraper (40 h
or NADL and 60 h for the Pe515 isolates), washed twice
ith PBS, and suspended at approximately 108 cells/ml
n ice-cold PBS containing 0.025% glutaraldehyde (Al-
rich, Dorset, UK). After 15-min incubation on ice, cells
ere washed three times with PBS, suspended at 108
cells/ml in RPMI 1640 medium (without serum), and thor-
oughly disrupted by sonication (Model W375 Cell Dis-
ruptor, Heat Systems, Ultrasonics, Farmingdale, NY). Cell
debris was removed by centrifugation at 600 g for 10 min
and the supernatant aspirated and stored at 280°C in
.2-ml aliquots (BVDV antigen). Mock-infected cells were
ncubated with PBS instead of virus and then processed
s described for the Pe515-infected cells (mock antigen).
single roller bottle (approximately 3 3 108 cells) pro-
vided 2.5 ml of antigen at approximately 4 mg/ml of total
protein.
Synthetic peptides
Synthetic peptides representing selected regions of
NS3 from NADL and Pe515ncp BVDV were prepared
using a BT7400 Multiple Peptide Synthesis system (Cam-
bridge Research Biologicals, Norwich, Cheshire, UK).
The sequences chosen for synthesis (Table 2) were
selected based on nonconservative amino acid substi-
tutions between the two viruses. Nine amino acids were
included on either side of a given substitution to allow for
the potential of MHC binding.
Bead-bound antigen
Viral proteins were affinity captured from sonicated
antigen using paramagnetic beads as described by
Hawke et al. (1992). Briefly, 4 3 107 goat anti-mouse IgG
eads (M-450; Dynal UK, Merseyside, UK) were washed
ix times with PBS to remove preservative. The beads
ere mixed with 50 mg anti-BVDV monoclonal antibody
iluted to 0.5 ml with PBS and incubated for 18 h at 4°C
ith continuous rotation. Antibody-coated beads were
ashed six times with PBS and diluted to 107 beads/ml
in complete RPMI. Beads (4 3 106) were incubated with
100 ml (approximately 100 mg total protein) of BVDV
ntigen diluted in 1 ml complete RPMI for 30 min at room
emperature with continuous rotation. Bead-bound anti-
79OGOUS BVDV BY PI CATTLEen was washed four times with PBS, irradiated with
ong-wavelength UV light (10,000 joules, 365 nm; Strata-
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EN ETlinker 1800), washed once with PBS, and suspended at
106 beads/ml in complete RPMI. Bead-bound antigen
as stored at 4°C.
itrocellulose-bound antigen
Nitrocellulose-bound antigen was prepared as de-
cribed previously (Collen and Doel, 1990). Briefly, mock
r BVDV antigen was diluted 1:1 with electrophoresis
ample buffer (0.2% SDS, 5% 2-mercaptoethanol, 20%
lycerol, 62.5 mM Tris, pH 6.8) and heated to 90°C for 5
in. Twenty micrograms total protein/lane was resolved
n a 12.5% discontinuous SDS–PAGE system, under re-
ucing conditions, using a Miniprotean II electrophoresis
ank (Bio-Rad, Hemel Hempstead, Hertfordshire, UK).
roteins were transferred to nitrocellulose using a Trans-
lot semidry blotter (Bio-Rad) and blocked with 5% (w/v)
emiskimmed milk in PBS containing 0.1% (v/v) NP40.
he locations of BVDV proteins were identified on a strip
ut from the edge of the membrane by incubation with a
:1000 dilution of 2331-B as the virus-specific probe fol-
owed, after washing, with a 1:1000 dilution of streptavi-
in-horseradish peroxidase conjugate. Bound conjugate
as visualized by the addition of PBS containing diami-
obenzidine (DAB, 1 mg/ml; Sigma D5637) and H2O2
(0.003% v/v) as the chromogen-substrate and NiCl (0.04%
w/v) to enhance the color. In the case of p80, the position
was confirmed by colocalization with molecular weight
markers. Nitrocellulose-bound antigen was prepared
from the region of the filter corresponding to 80 6 4 and
48–53 6 3 kDa, respectively, from both BVDV and mock
antigen blots.
Immunoprecipitation/immunoblot analysis
Confluent (90–95%) monolayers of MDBK cells were
infected with NADL, Pe515ncp, or Pe515cp at a m.o.i. of
5 or mock-infected with PBS and overlayed with mainte-
nance medium. At 24 h, the medium overlay was re-
moved and the cells detached using a cell scraper. Cells
were washed twice with a 1:10 dilution of TNE buffer (100
mM Tris, 500 mM NaCl, and 10 mM EDTA, pH 8.0) and
solubilized in TNE buffer containing 50 mM phenylmeth-
ylsulfonyl fluoride (PMSF), 0.1% sodium dodecyl sulfate
(SDS), and 0.5% NP40 (TNE lysis buffer). Cell lysates
were adsorbed overnight at 4°C with 10% fixed staphy-
lococcus (Protein A; Aldrich) in TNE lysis buffer, clarified
by centrifugation, and stored at 280°C until required.
Serum (20 ml) was mixed with 100 ml of cell lysate and
250 ml of TNE lysis buffer and mixed overnight at 4°C
with continuous rotation. Washed, immobilized Protein G
((80 ml; Aldrich) was added and the admix incubated for
further 4 h at 4°C. The immunosorbent was washed
nce with TNE lysis buffer and then four times with a 1:10
80 COLLilution of TNE buffer. Each sample was suspended in 30
ml of electrophoresis sample buffer, resolved under re-ducing conditions, and transferred to ECL-nitrocellulose
membrane as described for the preparation of nitrocel-
lulose-bound antigen. After blocking the membrane with
5% (w/v) semiskimmed milk in PBS containing 0.1% (v/v)
NP40, the membranes were probed and processed for
ECL visualization of proteins according to the manufac-
turer’s instructions (Amersham Life Science, Bucking-
hamshire, UK) using a 1:10,000 dilution of 2331-B as the
primary antibody and 1:10,000 streptavidin-HRP.
Neutralization assays
Neutralizing antibody was determined in an immuno-
peroxidase microplate assay (Smith et al., 1988). Test
sera were heated for 90 min at 60°C to inactivate any
persistent virus that was present. Sera were diluted in a
twofold series and 50 ml of diluted serum was mixed with
an equal volume of medium containing 100 TCID50 of
virus. The antibody–virus admix was incubated for 60
min at 37°C and then 50 ml transferred to the wells of a
6-well plate containing MDBK cells at 90–95% conflu-
nce. Cells and antibody–virus admix were incubated for
0 min at 37°C, after which the antibody–virus admix
as discarded and the cell monolayer washed once with
arm PBS. Wells were filled with 250 ml maintenance
edium and incubated for 5 days at 37°C, washed three
imes with warm PBS, and air-dried. Cell monolayers
ere fixed with PBS containing 20% acetone and 0.02%
SA for 30 min at room temperature, after which the
ixative was discarded and the cell monolayers allowed
o thoroughly air-dry. The presence of virus in fixed cells
as visualized by immunoperoxidase staining using
331-B as the BVDV probe.
ymphoproliferation assays
PBMC (105/well) were cultured in triplicate with anti-
en in 0.2 ml complete RPMI in 96-well round-bottom
lates for 6 days at 37°C with 5% CO2/95% air. Plates
were pulsed with 7.4 kBq/well of (methyl-3H)-thymidine
for the last 18 h of the assay and the cells were har-
vested onto glass-fiber filter mats using a Skatron har-
vester. Incorporation of radiolabel was determined using
a Beckman 1205 scintillation counter. Results are ex-
pressed as the geometric mean of c.p.m. for replicate
cultures.
In some experiments, live Pe515ncp virus was added
to proliferation assays at 0, 0.05, 0.5, 5, or 20 m.o.i. to
determine whether the presence of live virus affected the
ability of PBMC to respond to cell-sonicate antigens.
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